Details der Publikation - A Study of Superoxide Dismutase Mimetic GC4419 for the reduction of Severe Oral Mucositis (SOM) in patients with head and neck cancer

A Study of Superoxide Dismutase Mimetic GC4419 for the reduction of Severe Oral Mucositis (SOM) in patients with head and neck cancer : An Open Label Multi-Center Study of the Effects of Superoxide Dismutase Mimetic GC4419 when Administered to Reduce the Incidence and Severity of Severe Oral Mucositis (SOM) Associated with Chemoradiotherapy for Locally Advanced, NonMetastatic Head and Neck Cancer

Medienart:	Klinische Studie

Erscheinungsjahr:	2023
Erschienen:	2023

Enthalten in:	WHO International Clinical Trials Registry Platform - (2023) vom: 21. Juni Zur Gesamtaufnahme - year:2023

Sprache:	Englisch

Links:	Volltext [kostenfrei]

Themen:	610 Medical Condition: Severe Oral Mucositis (SOM) Associated with Chemoradiotherapy for Locally Advanced, Non-Metastatic Head and Neck Cancer MedDRA version: 20.0Level: LLTClassification code 10028130Term: Mucositis oralSystem Organ Class: 100000004856;Therapeutic area: Diseases [C] - Mouth and tooth diseases [C07] Phase: Phase 2 Recruitment Status: Authorised-recruitment may be ongoing or finished Study Type: Interventional

Anmerkungen:	WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 23-10-2019, Last updated: 2023-06-29

ICTRP ID:	EUCTR2019-002745-38-GB GTI-4419-202

Förderinstitution / Projekttitel:

PPN (Katalog-ID):	CTG00476580X

Internformat


LEADER	01000caa a22002652 4500
001	CTG00476580X
003	DE-627
005	20230629100629.0
007	cr uuu---uuuuu
008	210507s2023 xx \|\|\|\|\|o 00\| \|\|eng c
035			\|a (DE-627)CTG00476580X
035			\|a (UBBS_Klinische_Studien_WHO)EUCTR2019-002745-38-GB
035			\|a (UBBS_Klinische_Studien_WHO)GTI-4419-202
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
245	1	0	\|a A Study of Superoxide Dismutase Mimetic GC4419 for the reduction of Severe Oral Mucositis (SOM) in patients with head and neck cancer \|b An Open Label Multi-Center Study of the Effects of Superoxide Dismutase Mimetic GC4419 when Administered to Reduce the Incidence and Severity of Severe Oral Mucositis (SOM) Associated with Chemoradiotherapy for Locally Advanced, NonMetastatic Head and Neck Cancer
264		1	\|c 2023
336			\|a Text \|b txt \|2 rdacontent
337			\|a Computermedien \|b c \|2 rdamedia
338			\|a Online-Ressource \|b cr \|2 rdacarrier
500			\|a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 23-10-2019, Last updated: 2023-06-29
650		4	\|a Medical Condition: Severe Oral Mucositis (SOM) Associated with Chemoradiotherapy for Locally Advanced, Non-Metastatic Head and Neck Cancer MedDRA version: 20.0Level: LLTClassification code 10028130Term: Mucositis oralSystem Organ Class: 100000004856;Therapeutic area: Diseases [C] - Mouth and tooth diseases [C07]
650		4	\|a Study Type: Interventional
650		4	\|a Phase: Phase 2
650		4	\|a Recruitment Status: Authorised-recruitment may be ongoing or finished
650		4	\|a 610
773	0	8	\|i Enthalten in \|t WHO International Clinical Trials Registry Platform \|g (2023) vom: 21. Juni
773	1	8	\|g year:2023 \|g day:21 \|g month:06
856	4	0	\|u https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2019-002745-38 \|z kostenfrei \|3 Volltext
912			\|a GBV_CTG
951			\|a AR
952			\|j 2023 \|b 21 \|c 06

Zugang & Verfügbarkeit

Zugehörige Publikationen/Bände